Health
FDA to Review Safety Data for AstraZeneca COVID-19 Vaccine – Contagionlive.com
The agency requested data this week, following the pause of large-scale international assessment after a non-fatal serious adverse event was reported in a UK pa…
Scrutiny into the safety of the AstraZeneca and University of Oxford investigative coronavirus 2019 (COVID-19) vaccine candidate has not yet been eased.The US Food and Drug Administration (FDA) has started investigation into a serious adverse event reported by a UK-based volunteer participant in the phase 3 trial for adenovirus AZD1222, initially reported in the first week of September.
According to Reuters, the agency anticipates to receive requested safety data later this week, at which time …
-
Noosa News21 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Business22 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Noosa News21 hours agoAfter Hours Gallery Visits, French Dining and Garden Illuminations: Your Guide to the Ultimate Melbourne Culture Fix
-
General18 hours agoDeath of 86-year-old driver in Karoonda Highway crash prompts push for change